NCT07231471 Platelet Rich Plasma for Musculoskeletal Conditions
| NCT ID | NCT07231471 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Utah |
| Condition | Osteoarthritis (OA) |
| Study Type | INTERVENTIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2025-12-29 |
| Primary Completion | 2035-01-01 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The primary purpose of this study is to follow patients with various musculoskeletal (MSK) conditions over a one-year follow-up period after receiving a platelet rich plasma (PRP) injection, assessing changes in their pain levels, functional abilities, and overall patient satisfaction. This will develop a robust registry of patients treated with PRP for a range of MSK conditions. These conditions include, but are not limited to, osteoarthritis (OA) of the knee, hip, glenohumeral joint, elbow, ankle, and sacroiliac joint, as well as rotator cuff tendinopathy, lateral and medial epicondylitis, plantar fasciitis, patellar tendinopathy, Achilles tendinopathy, and proximal hamstring tendinopathy.
Eligibility Criteria
Inclusion Criteria: * 18+ years old * Musculoskeletal pathology that may benefit from a PRP injection * Failed other conservative treatments Exclusion Criteria: * No active malignancy * No active infection in the area of injection * No platelet disorder * No active systemic infections * No patients currently undergoing dialysis